Brown & Brown Reports Strong Revenue Growth Driven by Acquisitions, But Diluted EPS Declines Amid Significant Dilution
BRO is trading near its 52-week low of $65.68 (2.0% above the low) on elevated volume (2.6× avg).
Summary
Brown & Brown's 2025 annual report shows robust total revenue growth from major acquisitions, but diluted EPS declined significantly due to share issuance, and organic revenue growth slowed considerably.
Key Events · Earnings and Guidance · BRO
-
Strong Total Revenue Growth
Total revenues for 2025 increased by 22.8% to $5.902 billion, driven primarily by acquisitions and a 53.6% increase in profit-sharing contingent commissions.
-
Significant Dilution Impacts EPS
Despite a 6.1% increase in net income attributable to the company, diluted EPS decreased by 8.67% to $3.16 in 2025, largely due to the issuance of 43.1 million shares of common stock.
-
Organic Revenue Growth Slowdown
Organic revenue growth decelerated significantly to 2.8% in 2025, down from 10.4% in 2024, indicating a slowdown in core business performance.
-
Major Acquisition and Financing
The company completed 43 acquisitions in 2025, including the $9.608 billion Accession Risk Management Group. This was funded by issuing $4.315 billion in common stock and $4.2 billion in senior notes, leading to a substantial increase in total debt from $3.824 billion to $7.613 billion.
Analysis · BRO · Finance
Brown & Brown's 2025 annual report reveals a year of substantial growth through acquisitions, notably the $9.608 billion Accession Risk Management Group, which significantly expanded total revenues and assets. However, this growth came at a considerable cost to existing shareholders, as diluted EPS decreased by 8.67% due to the large issuance of common stock to fund these deals. Furthermore, the core business showed a notable slowdown in organic revenue growth, dropping from 10.4% in 2024 to 2.8% in 2025, indicating challenges in underlying operational performance. The exclusion of several significant 2025 acquisitions from management's internal control assessment, representing a material portion of the company's assets and revenues, introduces a governance and risk concern. Investors should weigh the strategic expansion and increased dividend against the significant dilution, decelerating organic growth, and increased debt levels, especially with the stock trading near 52-week lows.
At the time of this filing, BRO was trading at $66.99 on NYSE in the Finance sector, with a market capitalization of approximately $22.9B. The 52-week trading range was $65.68 to $125.68. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.